This document discusses the sterile compounding environment, including the setup and characteristics of anterooms and clean rooms. It describes the ISO classification levels for particulate matter in these areas and different types of hoods used for sterile compounding. USP Chapter <797> guidelines for hoods and the four risk levels for sterile compounding are also summarized.
Cleaning and Disinfecting iv Hoods and RoomsJerry Fahrni
There are plenty of rules regarding when and how pharmacy iv rooms should be cleaned and disinfected. This presentation gives a basic overview of those rules as found in USP Chapter <797>
Cleaning and Disinfecting iv Hoods and RoomsJerry Fahrni
There are plenty of rules regarding when and how pharmacy iv rooms should be cleaned and disinfected. This presentation gives a basic overview of those rules as found in USP Chapter <797>
This presentation contains general guidelines and basic requirements of manufacturing of sterile medicinal products. This presentation is useful for training to the people involved in manufacturing of sterile pharmaceuticals or medicines.
Control on Cleanroom Environmental Monitoring (Pharmaceutical)Srinath Sasidharan
A general consideration of Environmental Monitoring in Pharmaceutical manufacturing area. Cleanroom Monitoring Tools and Utilities: Author Sreenath Sasidharan (Geltec Healthcare FZE)
This presentation contains general guidelines and basic requirements of manufacturing of sterile medicinal products. This presentation is useful for training to the people involved in manufacturing of sterile pharmaceuticals or medicines.
Control on Cleanroom Environmental Monitoring (Pharmaceutical)Srinath Sasidharan
A general consideration of Environmental Monitoring in Pharmaceutical manufacturing area. Cleanroom Monitoring Tools and Utilities: Author Sreenath Sasidharan (Geltec Healthcare FZE)
GMP Requirements for Sterile Products manufacturingsurafel kebede
This training module is prepared based on (Annex 6. TRS 961, 2011) & trainees are highly recommended to read this document together with Annex 6. TRS 961, 2011.
GMP Requirements for Sterile Products manufacturingsurafel kebede
This training module is prepared based on (Annex 6. TRS 961, 2011) & trainees are highly recommended to read this document together with Annex 6. TRS 961, 2011.
TRAINING MODULE FOR IMPLEMENTATION OF GOOD MANUFACTURING PRACTICES FOR STERILE PRODUCT MANUFACTURING.
This training module is prepared based on (Annex 6. TRS 961, 2011) & readers are highly recommended to see this document in conjunction with Annex 6. TRS 961, 2011.
AAF has created a new whitepaper with in-depth insights into air filtration challenges and answers for dry heat sterilization tunnels. View our webinar and receive access to the full document at http://hthepa.aafeurope.com/
FACTORS IN THE DESIGN OF PARENTERAL PRODUCTION FACILITIESNEHA SINGH
THIS PRESENTATION DESCRIBE ABOUT DIFFERENT FACTORS RELATED TO PARENTERAL PREPARATION OR PRODUCTION MAINLY AND HAVE DIFFERENT SPECIAL TERMS RELATED TO PARENTERAL DEPARTMENT ,BENEFECIAL FOR THE PHARMACY STUDENTS BOTH B.PHARM OR M.PHARM OR BIOTECHNOLOGY MAINLY
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
3. Topics3
Learning Objectives
Identify the origin of the pharmacy clean room and procedures
for sterile compounding.
Describe anteroom and clean room setup and characteristics.
Understand the various ISO levels that are appropriate for
sterile compounding.
Identify the different types of hoods used for sterile
compounding.
Classify the four sterile compounding risk levels.
Recognize potential contaminants in the sterile compounding
environment.
2012 Paradigm Publishing
4. Topics4
Topics
Learning Objectives
Introduction
Anteroom Setup and Characteristics
Clean Room Setup and Characteristics
Cleaning of the Anteroom and Clean Room
Types of Hoods Required for Sterile Compounding
USP Chapter <797> Guidelines for Hoods
Risk Levels in Sterile Compounding
Chapter Summary
2012 Paradigm Publishing
In Slide Show view, click
the desired topic to the
left to link directly to the
related slide. To return
to this slide at any point
in the presentation, click
the Topics button below.
5. Topics55
Introduction
Some changes necessitated by USP Chapter <797>
have required pharmacies to undergo extensive and
costly renovations
Specialized HVAC equipment, clean rooms
constructed of nonporous materials, and strictly
regulated air pressure and humidity control serve to
create appropriate anteroom and clean-room
environments that are low in particulate matter
2012 Paradigm Publishing
6. Topics66
Anteroom Setup and Characteristics
The anteroom, which may also be called the
transition area or ante-area, provides a space where
sterile compounding personnel can garb and perform
aseptic hand washing
a place to stage components and supplies prior to entering
the clean room
serves as a transition area that helps to maintain required
air pressure levels
2012 Paradigm Publishing
7. Topics77
Anteroom Setup and
Characteristics…/2
Most sterile compounding
pharmacies have an
anteroom that is separate
from the clean room
small facilities that perform
only low- or medium-risk
sterile compounding may
create an ante-area that is
separated from the clean
room by a simple line of
demarcation
2012 Paradigm Publishing
8. Topics88
Anteroom Setup and
Characteristics…/3
Most sterile compounding pharmacies secure a
sticky mat to the floor at the doorway leading into
the clean room
placed on the less sterile side of that doorway
intended to help compounders avoid tracking dirt into the
sterile compounding area
At a designated frequency, you must remove the top
layer of the mat to expose a fresh sticky surface
refer to your pharmacy’s Policy and Procedure (P&P)
manual
2012 Paradigm Publishing
9. Topics99
Anteroom Setup and
Characteristics…/4
Limit storage items to materials that are directly
required for sterile compound preparation
syringes, needles, vials, and supplies used in aseptic hand
washing or hood cleaning procedures
Avoid storing compounding supplies long-term
Never store materials with a high potential for
shedding
Wipe down all supplies with sterile 70% isopropyl
alcohol (IPA) prior to transporting them
2012 Paradigm Publishing
11. Topics1111
Clean Room Setup and
Characteristics
The clean room is the innermost room
also referred to as the IV room or the buffer area
Access is restricted to properly trained and garbed
personnel
Bring only those supplies needed
Do not locate computers, printers, or other devices
into the clean room
Surfaces must be smooth, nonporous, and easy to
clean.
2012 Paradigm Publishing
12. Topics1212
Clean Room Setup and
Characteristics…/2
A pharmacy-designated HVAC system should pump
HEPA-filtered air into the clean room to create a
positive-pressure environment
ensures that the airflow moves from the clean room
outward, through the anteroom, and continuing in the
direction of the outer pharmacy area
helps to minimize the travel of dust, spores, and other
particles from the outer rooms into the clean room
2012 Paradigm Publishing
13. Topics1313
Clean Room Setup and
Characteristics…/3
PECs, such as horizontal laminar airflow hoods, should
be placed within the clean room
within each airflow hood, the area closest to the hood’s
HEPA filter is called the direct compounding area (DCA) and
also referred to as “first air”
you perform sterile compounding procedures in the DCA
To avoid disrupting the airflow from the HEPA filter,
personnel working in the hood should minimize their
movements
2012 Paradigm Publishing
14. Topics1414
Cleaning of the Anteroom and Clean
Room
USP Chapter <797> provides clear guidelines for the
cleaning of the pharmacy’s anteroom and clean
room
disinfect countertops and other surfaces
mop floors with a nonshedding mop
designate cleaning supplies
wipe down the walls, ceilings, and storage bins
2012 Paradigm Publishing
15. Topics1515
Maximum Particle Count
ISO Class Name (in particles of 0.5 micron and larger per cubic meter of
air)
3 35.2
4 352
5* 3520
6 35,200
7 352,000
8 3,520,000
2012 Paradigm Publishing
Cleaning of the Anteroom and Clean
Room…/2
*The ISO Class 5 rating is synonymous with “Class 100.”
16. Topics1616
Cleaning of the Anteroom and Clean
Room…/3
The International Organization for Standardization
(ISO) creates worldwide industrial and commercial
standards that often become law
USP Chapter <797> identifies several ISO categories,
or classes, that classify the amount of particulate
matter in room air
numbered from Class 3 to Class 8, with a higher number
designating a greater allowance for particulate matter
2012 Paradigm Publishing
17. Topics1717
Cleaning of the Anteroom and Clean
Room…/4
In general, the particulate matter contained in
regular room air within a pharmacy should be at or
above the ISO Class 8 range
At the next level of stringency, the particulate matter
in the pharmacy anteroom must be no greater than
ISO Class 8
Stricter still, the particulate matter in the clean room
should be no more than ISO Class 7
The air within the DCA of a hood must be ISO Class 5
2012 Paradigm Publishing
18. Topics1818
Cleaning of the Anteroom and Clean
Room…/5
You must record the same information about the
clean-room-cleaning procedures as you record about
anteroom-cleaning procedures
do so on separate clean-room-cleaning log sheets
2012 Paradigm Publishing
21. Topics21
Your Turn
2012 Paradigm Publishing
1) This a place where sterile compounding personnel can garb and
perform aseptic hand washing.
a. clean room
b. employee lounge
c. anteroom
d. supply room
2) The particulate matter in the clean room should be no more than
a. ISO Class 4.
b. ISO Class 5.
c. ISO Class 6.
d. ISO Class 7.
In Slide Show view,
click here to see
the answer to
Question 1. Then
click again to
advance to
Question 2.
In Slide Show view,
click here to see
the answer to
Question 2.
22. Topics2222
Types of Hoods Required
for Sterile Compounding
All of the different hood types may be referred to as
primary engineering control (PEC)
Sterile compounding personnel perform their work in
the following hood types: the compounding aseptic
isolator (CAI), the compounding aseptic
containment isolator (CACI), the biological safety
cabinet (BSC), and the laminar airflow workbench
(LAFW)
the hoods’ design, function, and operation differ in a
number of important ways
2012 Paradigm Publishing
23. Topics2323
Types of Hoods Required
for Sterile Compounding…/2
The most widely used
sterile compounding
hood in the pharmacy
is the horizontal LAFW
2012 Paradigm Publishing
24. Topics2424
Types of Hoods Required
for Sterile Compounding…/3
CAI and CACI Hoods
most useful in sterile compounding
environments where relatively few
preparations are made each day
may also be called a barrier isolator
or an isolator cabinet
personnel place their hands inside
the gloves and reach through the
inner pass-through window
CACI provides greater protection for
the worker
2012 Paradigm Publishing
25. Topics2525
Types of Hoods Required
for Sterile Compounding…/4
Advantages of the CAI and CACI Hoods
two primary advantages: offers a safer environment for the
worker, and it is not mandatory to place them in an ISO
Class 7 environment
Disadvantages of the CAI and CACI Hoods
limited capacity, increased demand on the worker’s time,
and logistical issues or costs associated with proper
venting
2012 Paradigm Publishing
26. Topics2626
Types of Hoods Required
for Sterile Compounding…/5
BSC Hood
special hood for preparing
hazardous compounds such
as antineoplastic drugs and
other chemotherapy
medications
the worker stands behind
the shield and places the
hands into the cabinet to
manipulate the sterile
compound
2012 Paradigm Publishing
27. Topics2727
USP Chapter <797> Guidelines for
Hoods
Most hoods share a
common design such that
room air enters the cabinet
through a prefilter that
filters out large particles
that might damage the
HEPA filter
keep the prefilter-
replacement checklist in a
plastic sheet protector in the
anteroom
2012 Paradigm Publishing
29. Topics2929
USP Chapter <797> Guidelines for
Hoods…/3
Each hood should have its
own, separate checklist
Keep the checklists inside a
plastic sleeve or sheet
protector that can be
wiped down to prevent
dust buildup
Always place the checklists
in the same designated
location in the anteroom
2012 Paradigm Publishing
30. Topics3030
Risk Levels in Sterile Compounding
USP Chapter <797> defines four microbial
contamination risk levels associated with the
creation of CSPs
The risk levels are provided as a guide for sterile
compounding personnel to determine the potential
for contamination in various compounding scenarios
The pharmacy supervisor is responsible for
determining the risk level of CSPs
2012 Paradigm Publishing
31. Topics3131
Risk Levels in Sterile
Compounding…/2
Low-Risk CSPs
involves the mixing of no more than three commercially
packaged sterile products, and no more than two separate
injections into the sterile container, all done aseptically,
within an ISO Class 5 workbench
many low-risk CSPs are prepared daily in every IV room
2012 Paradigm Publishing
32. Topics3232
Risk Levels in Sterile
Compounding…/3
Medium-Risk CSPs
meets all of the conditions associated with low-risk sterile
product preparation and also involve other, more complex,
sterile compounding procedures
the preparation of a total parenteral nutrition (TPN)
solution is a medium-risk activity because it involves
multiple injections of several medications into an IV bag
that is designed to be administered over a 24-hour period
2012 Paradigm Publishing
33. Topics3333
Risk Levels in Sterile
Compounding…/4
High-Risk CSPs
meet all of the conditions of the low- and medium-risk
groups and also involve the preparation of medications
wherein one or more of the products being prepared is not
sterile or the product is prepared in an environment that is
less stringently controlled, or more risky, than ISO Class 5
the two most common sterilization methods include
filtration sterilization, which is accomplished by passing
the liquid medication through a 0.2-micron filter, or heat
sterilization, which is achieved by autoclaving the
compounded solution
2012 Paradigm Publishing
34. Topics3434
Risk Levels in Sterile
Compounding…/5
Immediate-Use CSPs
according to the USP <797> Guidebook, are “intended only
for those situations where there is a need for emergency,
or immediate, patient administration of a CSP
must be administered within one hour of preparation
2012 Paradigm Publishing
35. Topics3535
Risk Levels in Sterile
Compounding…/6
Potential Contaminants in the Sterile Compounding
Environment
pathogenic contaminants may include bacteria, viruses,
fungi, hair, dander, or particulate matter
touch contamination carries the potential for serious harm
to the patient
shadowing is caused by incorrect technique
the area immediately behind an item within the hood is a
zone of turbulence and is considered to be contaminated
2012 Paradigm Publishing
37. Topics3737
Risk Levels in Sterile
Compounding…/8
Potential Contaminants in the Sterile Compounding
Environment…continued
the six-inch band along the outer edge of the hood is a
poor environment for preparing sterile products
you may hear this area referred to as the six-inch zone or
the contamination zone of the hood
inspect all parenteral preparations for precipitates and
particulate matter
incorrect needle insertion can lead to coring
additives that are incompatible might form a precipitate or
show other evidence of incompatibility
2012 Paradigm Publishing
38. Topics3838
Risk Levels in Sterile
Compounding…/9
Excellent aseptic technique is the foundation of
sterile parenteral product preparation
As an IV technician, you must ensure that all policies
and procedures are followed at all times
Failure to follow aseptic technique guidelines may
lead to contaminated parenteral products that could
transfer pathogens to patients
Appropriate conduct in the clean room, combined
with correct technique and careful inspection of final
products, will help to guarantee the sterility of CSPs
2012 Paradigm Publishing
39. Topics39
Your Turn
2012 Paradigm Publishing
3) All of the different hood types may be referred to as
a. primary engineering control.
b. secondary engineering control.
c. primary engineering class.
d. secondary engineering class.
4) This is caused by incorrectly placing objects within the hood.
a. shadowing
b. touch contamination
c. zone of turbulence
d. pathogenic contaminants
In Slide Show view,
click here to see
the answer to
Question 3. Then
click again to
advance to
Question 4.
In Slide Show view,
click here to see
the answer to
Question 4.